GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Total Payout Yield %

Australian Clinical Labs (ASX:ACL) Total Payout Yield % : 21.15 (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Australian Clinical Labs's current Total Payout Yield % is 21.15%.


Australian Clinical Labs Total Payout Yield % Historical Data

The historical data trend for Australian Clinical Labs's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Total Payout Yield % Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23
Total Payout Yield %
- -15.19 3.15 14.08

Australian Clinical Labs Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Payout Yield % Get a 7-Day Free Trial - 5.24 27.69 4.08 4.94

Competitive Comparison of Australian Clinical Labs's Total Payout Yield %

For the Diagnostics & Research subindustry, Australian Clinical Labs's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Australian Clinical Labs's Total Payout Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Australian Clinical Labs's Total Payout Yield % falls into.



Australian Clinical Labs Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Australian Clinical Labs's Total Payout Yield % for the fiscal year that ended in Jun. 2023 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (-0.891 + 0 + -96.88) / 694.30896
=14.08%

Australian Clinical Labs's annualized Total Payout Yield % for the quarter that ended in Dec. 2023 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + -14.303) * 2 / 579.45367
=4.94%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Australian Clinical Labs Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Australian Clinical Labs Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Australian Clinical Labs (ASX:ACL) Business Description

Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines